Cozad Asset Management Inc Bristol Myers Squibb CO Transaction History

Cozad Asset Management Inc

$1.02 Billion
Q3 2024

A detailed history of Cozad Asset Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cozad Asset Management Inc holds 5,972 shares of BMY stock, worth $347,749. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,972

Previous 6,088 1.91%

Holding current value

$347,749

Previous $252,000 22.62%

% of portfolio

0.03%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$39.66 - $51.75 $4,600 - $6,003	-116 Reduced 1.91%	5,972 $309,000
Q2 2024 Aug 02, 2024	SELL	$40.25 - $52.99 $39,042 - $51,400	-970 Reduced 13.74%	6,088 $252,000
Q1 2024 May 08, 2024	SELL	$47.98 - $54.4 $41,022 - $46,512	-855 Reduced 10.81%	7,058 $382,000
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $67,920 - $81,047	-1,401 Reduced 15.04%	7,913 $406,000
Q3 2023 Nov 02, 2023	SELL	$57.89 - $64.73 $34,791 - $38,902	-601 Reduced 6.06%	9,314 $540,000
Q2 2023 Jul 26, 2023	SELL	$63.71 - $70.74 $8,537 - $9,479	-134 Reduced 1.33%	9,915 $634,000
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $15,704 - $17,812	239 Added 2.44%	10,049 $696,000
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $132,988 - $157,476	1,942 Added 24.68%	9,810 $705,000
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $1 - $691	-9 Reduced 0.11%	7,868 $559,000
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $1,670 - $1,839	23 Added 0.29%	7,877 $607,000
Q1 2022 Apr 29, 2022	BUY	$61.48 - $73.72 $89,146 - $106,894	1,450 Added 22.64%	7,854 $574,000
Q4 2021 Feb 01, 2022	SELL	$53.63 - $62.52 $6,221 - $7,252	-116 Reduced 1.78%	6,404 $399,000
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $38,460 - $45,051	-650 Reduced 9.07%	6,520 $386,000
Q2 2021 Jul 29, 2021	SELL	$61.91 - $67.42 $38,693 - $42,137	-625 Reduced 8.02%	7,170 $479,000
Q1 2021 Apr 29, 2021	SELL	$59.34 - $66.74 $45,276 - $50,922	-763 Reduced 8.92%	7,795 $492,000
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $80,547 - $91,274	-1,395 Reduced 14.02%	8,558 $531,000
Q3 2020 Oct 28, 2020	BUY	$57.43 - $63.64 $57 - $63	1 Added 0.01%	9,953 $600,000
Q2 2020 Aug 07, 2020	SELL	$54.82 - $64.09 $9,977 - $11,664	-182 Reduced 1.8%	9,952 $585,000
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $9,280 - $13,486	-200 Reduced 1.94%	10,134 $565,000
Q4 2019 Jan 16, 2020	BUY	$49.21 - $64.19 $179,321 - $233,908	3,644 Added 54.47%	10,334 $663,000
Q3 2019 Oct 31, 2019	SELL	$42.77 - $50.71 $213 - $253	-5 Reduced 0.07%	6,690 $339,000
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $24,094 - $26,643	-540 Reduced 7.46%	6,695 $304,000
Q1 2019 Apr 18, 2019	SELL	$45.12 - $53.8 $21,883 - $26,093	-485 Reduced 6.28%	7,235 $345,000
Q4 2018 Jan 14, 2019	SELL	$48.76 - $63.23 $294,510 - $381,909	-6,040 Reduced 43.9%	7,720 $401,000
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $12,362 - $13,944	-224 Reduced 1.6%	13,760 $854,000
Q2 2018 Aug 15, 2018	BUY	$50.53 - $62.98 $706,611 - $880,712	13,984 New	13,984 $774,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cozad Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cozad Asset Management Inc with notifications on news.

Account

Cozad Asset Management Inc Bristol Myers Squibb CO Transaction History